Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 108516, 11 pages
http://dx.doi.org/10.1155/2014/108516
Review Article

Vitamin B6-Dependent Enzymes in the Human Malaria Parasite Plasmodium falciparum: A Druggable Target?

1Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes 1374, 05508-000 São Paulo, SP, Brazil
2Multi User Center for Biomolecular Innovation, Department of Physics, São Paulo State University, UNESP/IBILCE, C. Postal 136, 15054-000 São José do Rio Preto, SP, Brazil
3Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), Avenida Doctor Eneas de Carvalho Aguiar 44, 05403-000 São Paulo, SP, Brazil

Received 17 May 2013; Revised 24 October 2013; Accepted 28 November 2013; Published 9 January 2014

Academic Editor: Ashley M. Buckle

Copyright © 2014 Thales Kronenberger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. (WHO), WHO, Geneva, Switzerland, 2011.
  2. S. Sabbatani, S. Fiorino, and R. Manfredi, “The emerging of the fifth malaria parasite (Plasmodium Knowlesi). A public health concern?” Brazilian Journal of Infectious Diseases, vol. 14, no. 3, pp. 299–309, 2010. View at Google Scholar · View at Scopus
  3. B. M. Greenwood, D. A. Fidock, D. E. Kyle et al., “Malaria: progress, perils, and prospects for eradication,” Journal of Clinical Investigation, vol. 118, no. 4, pp. 1266–1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Cohen, D. L. Smith, C. Cotter et al., “Malaria resurgence: a systematic review and assessment of its causes,” Malaria Journal, vol. 11, article 122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. D. G. Heppner, “The malaria vaccine—status quo 2013,” Travel Medicine and Infectious Disease, vol. 11, pp. 2–7, 2013. View at Google Scholar
  6. E. M. Riley and V. A. Stewart, “Immune mechanisms in malaria: new insights in vaccine development,” Nature Medicine, vol. 19, pp. 168–178, 2013. View at Google Scholar
  7. T. Kronenberger, I. Schettert, and C. Wrenger, “Targeting the vitamin biosynthesis pathways for the treatment of malaria,” Future Medicinal Chemistry, vol. 5, no. 7, pp. 769–779, 2013. View at Publisher · View at Google Scholar
  8. A. Nzila, S. A. Ward, K. Marsh, P. F. G. Sims, and J. E. Hyde, “Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy,” Trends in Parasitology, vol. 21, no. 6, pp. 292–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. N. Burrows, “Antimalarial drug discovery: where next?” Future Medicinal Chemistry, vol. 4, no. 18, pp. 2233–2235, 2012. View at Publisher · View at Google Scholar
  10. A. Bhattarai, A. S. Ali, S. P. Kachur et al., “Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar,” PLoS Medicine, vol. 4, no. 11, article e309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Olliaro, “Mode of action and mechanisms of resistance for antimalarial drugs,” Pharmacology and Therapeutics, vol. 89, no. 2, pp. 207–219, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. I. B. Müller and J. E. Hyde, “Antimalarial drugs: modes of action and mechanisms of parasite resistance,” Future Microbiology, vol. 5, no. 12, pp. 1857–1873, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. I. B. Müller, J. E. Hyde, and C. Wrenger, “Vitamin B metabolism in Plasmodium falciparum as a source of drug targets,” Trends in Parasitology, vol. 26, no. 1, pp. 35–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Friedrich, Vitamins, Walter de Gruyter, Berlin, Germany, 1988.
  15. R. Percudani and A. Peracchi, “A genomic overview of pyridoxal-phosphate-dependent enzymes,” EMBO Reports, vol. 4, no. 9, pp. 850–854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. T. B. Fitzpatrick, N. Amrhein, B. Kappes, P. Macheroux, I. Tews, and T. Raschle, “Two independent routes of de novo vitamin B6 biosynthesis: not that different after all,” Biochemical Journal, vol. 407, no. 1, pp. 1–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. M. Lam, E. Tancula, W. B. Dempsey, and M. E. Winkler, “Suppression of insertions in the complex pdxJ operon of Escherichia coli K-12 by lon and other mutations,” Journal of Bacteriology, vol. 174, no. 5, pp. 1554–1567, 1992. View at Google Scholar · View at Scopus
  18. B. B. Roa, D. M. Connolly, and M. E. Winkler, “Overlap between pdxA and ksgA in the complex pdxA-ksgA-apaG-apaH operon of Escherichia coli K-12,” Journal of Bacteriology, vol. 171, no. 9, pp. 4767–4777, 1989. View at Google Scholar · View at Scopus
  19. J. Knöckel, I. B. Müller, B. Bergmann, R. D. Walter, and C. Wrenger, “The apicomplexan parasite Toxoplasma gondii generates pyridoxal phosphate de novo,” Molecular and Biochemical Parasitology, vol. 152, no. 1, pp. 108–111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Wrenger, M. Eschbach, I. B. Müller, D. Warnecke, and R. D. Walter, “Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum,” The Journal of Biological Chemistry, vol. 280, no. 7, pp. 5242–5248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Gengenbacher, T. B. Fitzpatrick, T. Raschle et al., “Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights,” The Journal of Biological Chemistry, vol. 281, no. 6, pp. 3633–3641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ehrenshaft, P. Bilski, M. Li, C. F. Chignell, and M. E. Daub, “A highly conserved sequence is a novel gene involved in de novo vitamin B6 biosynthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9374–9378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ehrenshaft, A. E. Jenns, K. R. Chung, and M. E. Daub, “SOR1, a gene required for photosensitizer and singlet oxygen resistance in Cercospora fungi, is highly conserved in divergent organisms,” Molecular Cell, vol. 1, no. 4, pp. 603–609, 1998. View at Google Scholar · View at Scopus
  24. M. Strohmeier, T. Raschle, J. Mazurkiewicz et al., “Structure of a bacterial pyridoxal 5′-phosphate synthase complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 51, pp. 19284–19289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Zhu, J. W. Burgner, E. Harms, B. R. Belitsky, and J. L. Smith, “A new arrangement of (β/α)8 barrels in the synthase subunit of PLP synthase,” The Journal of Biological Chemistry, vol. 280, no. 30, pp. 27914–27923, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. I. B. Müller, J. Knöckel, M. R. Groves et al., “The assembly of the plasmodial PLP synthase complex follows a defined course,” PLoS ONE, vol. 3, no. 3, Article ID e1815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. B. Reeksting, I. B. Müler, P. B. Burger et al., “Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum,” Biochemical Journal, vol. 449, no. 1, pp. 175–187, 2013. View at Publisher · View at Google Scholar
  28. J. Knöckel, I. B. Müller, S. Butzloff, B. Bergmann, R. D. Walter, and C. Wrenger, “The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference,” Biochemical Journal, vol. 443, no. 2, pp. 397–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Becker, L. Tilley, J. L. Vennerstrom, D. Roberts, S. Rogerson, and H. Ginsburg, “Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions,” International Journal for Parasitology, vol. 34, no. 2, pp. 163–189, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Müller, “Redox and antioxidant systems of the malaria parasite Plasmodium falciparum,” Molecular Microbiology, vol. 53, no. 5, pp. 1291–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Knöckel, B. Bergmann, I. B. Müller, S. Rathaur, R. D. Walter, and C. Wrenger, “Filling the gap of intracellular dephosphorylation in the Plasmodium falciparum vitamin B1 biosynthesis,” Molecular and Biochemical Parasitology, vol. 157, no. 2, pp. 241–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. I. B. Müller, F. Wu, B. Bergmann et al., “Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum,” PLoS ONE, vol. 4, no. 2, Article ID e4406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Amadasi, M. Bertoldi, R. Contestabile et al., “Pyridoxal 5′-phosphate enzymes as targets for therapeutic agents,” Current Medicinal Chemistry, vol. 14, no. 12, pp. 1291–1324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Maenpuen, K. Sopitthummakhun, Y. Yuthavong, P. Chaiyen, and U. Leartsakulpanich, “Characterization of Plasmodium falciparum serine hydroxymethyltransferase—a potential antimalarial target,” Molecular and Biochemical Parasitology, vol. 168, no. 1, pp. 63–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. K. T. Pang, J. H. Hunter, R. Gujjar et al., “Catalytic and ligand-binding characteristics of Plasmodium falciparum serine hydroxymethyltransferase,” Molecular and Biochemical Parasitology, vol. 168, no. 1, pp. 74–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Varadharajan, S. Dhanasekaran, Z. Q. Bonday, P. N. Rangarajan, and G. Padmanaban, “Involvement of δ-aminolaevulinate synthase encoded by the parasite gene in de novo haem synthesis by Plasmodium falciparum,” Biochemical Journal, vol. 367, no. 2, pp. 321–327, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Wrenger, I. B. Müller, A. J. Schifferdecker, R. Jain, R. Jordanova, and M. R. Groves, “Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum,” Journal of Molecular Biology, vol. 405, no. 4, pp. 956–971, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Gafan, J. Wilson, L. C. Berger, and B. J. Berger, “Characterization of the ornithine aminotransferase from Plasmodium falciparum,” Molecular and Biochemical Parasitology, vol. 118, no. 1, pp. 1–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Birkholtz, F. Joubert, A. W. H. Neitz, and A. I. Louw, “Comparative properties of a three-dimensional model of Plasmodium falciparum ornithine decarboxylase,” Proteins, vol. 50, no. 3, pp. 464–473, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. L. M. Birkholtz, C. Wrenger, F. Joubert, G. A. Wells, R. D. Walter, and A. I. Louw, “Parasite-specific inserts in the bifunctional S-adenosylmethionine decarboxylase/ornithine decarboxylase of Plasmodium falciparum modulate catalytic activities and domain interactions,” Biochemical Journal, vol. 377, no. 2, pp. 439–448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Krause, K. Lüersen, C. Wrenger, T. W. Gilberger, S. Müller, and R. D. Walter, “The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylmethionine decarboxylase of Plasmodium falciparum: recombinant expression and catalytic properties of two different constructs,” Biochemical Journal, vol. 352, no. 2, pp. 287–292, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Wrenger, K. Lüersen, T. Krause, S. Müller, and R. D. Walter, “The Plasmodium falciparum bifunctional ornithine decarboxylase, S-adenosyl-L-methionine decarboxylase, enables a well balanced polyamine synthesis without domain-domain interaction,” The Journal of Biological Chemistry, vol. 276, no. 32, pp. 29651–29656, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. A. C. van Brumelen, K. L. Olszewski, D. Willinski, M. Llinás, A. I. Louw, and L. Birkholtz, “Co-inhibition of Plasmodium falciparum S-Adenosylmethionine decarboxylase/ornithine decarboxylase reveals perturbation-specific compensatory mechanisms by transcriptome, proteome, and metabolome analyses,” The Journal of Biological Chemistry, vol. 284, no. 7, pp. 4635–4646, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Williams, J. Sprenger, E. Human et al., “Biochemical characterisation and novel classification of monofunctional S-adenosylmethionine decarboxylase of Plasmodium falciparum,” Molecular and Biochemical Parasitology, vol. 180, no. 1, pp. 17–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Rossi, S. Garavaglia, G. B. Giovenzana, B. Arcà, J. Li, and M. Rizzi, “Crystal structure of the Anopheles gambiae 3-hydroxykynurenine transaminase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 15, pp. 5711–5716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. Phillips, P. Coffino, and C. C. Wang, “Trypanosoma brucei ornithine decarboxylase: enzyme purification, characterization, and expression in Escherichia coli,” The Journal of Biological Chemistry, vol. 263, no. 34, pp. 17933–17941, 1988. View at Google Scholar · View at Scopus
  47. Y. G. Assaraf, J. Golenser, D. T. Spira, and U. Bachrach, “Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, Plasmodium falciparum,” Biochemical Journal, vol. 222, no. 3, pp. 815–819, 1984. View at Google Scholar · View at Scopus
  48. Y. G. Assaraf, C. Kahana, D. T. Spira, and U. Bachrach, “Plasmodium falciparum: purification, properties, and immunochemical study of ornithine decarboxylase, the key enzyme in polyamine biosynthesis,” Experimental Parasitology, vol. 67, no. 1, pp. 20–30, 1988. View at Google Scholar · View at Scopus
  49. S. H. Seabra, R. A. DaMatta, F. G. de Mello, and W. de Souza, “Endogenous polyamine levels in macrophages is sufficient to support growth of Toxoplasma gondii,” Journal of Parasitology, vol. 90, no. 3, pp. 455–460, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Derouin and C. Chastang, “Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture,” Antimicrobial Agents and Chemotherapy, vol. 32, no. 3, pp. 303–307, 1988. View at Google Scholar · View at Scopus
  51. M. Dixon and E. C. Webb, Enzymes, Academic Press, New York, NY, USA, 1979.
  52. S. D. Copley, “Enzymes with extra talents: moonlighting functions and catalytic promiscuity,” Current Opinion in Chemical Biology, vol. 7, no. 2, pp. 265–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. R. A. John, “Pyridoxal phosphate-dependent enzymes,” Biochimica et Biophysica Acta, vol. 1248, no. 2, pp. 81–96, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. A. J. Romo and H. W. Liu, “Mechanisms and structures of vitamin B6-dependent enzymes involved in deoxy sugar biosynthesis,” Biochimica et Biophysica Acta, vol. 1814, no. 11, pp. 1534–1547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Palm, H. W. Klein, R. Schinzel, M. Buehner, and E. J. M. Helmreich, “The role of pyridoxal 5′-phosphate in glycogen phosphorylase catalysis,” Biochemistry, vol. 29, no. 5, pp. 1099–1107, 1990. View at Google Scholar · View at Scopus
  56. J. F. Kirsch, G. Eichele, G. C. Ford et al., “Mechanism of action of aspartate aminotransferase proposed on the basis of its spatial structure,” Journal of Molecular Biology, vol. 174, no. 3, pp. 497–525, 1984. View at Google Scholar · View at Scopus
  57. P. K. Mehta and P. Christen, “The molecular evolution of pyridoxal-5′-phosphate-dependent enzymes,” Advances in Enzymology and Related Areas of Molecular Biology, vol. 74, pp. 129–184, 2000. View at Google Scholar · View at Scopus
  58. P. Christen and P. K. Mehta, “From cofactor to enzymes. The molecular evolution of pyridoxal-5′-pliosphate-dependent enzymes,” Chemical Records, vol. 1, no. 6, pp. 436–447, 2001. View at Google Scholar · View at Scopus
  59. B. Kappes, I. Tews, A. Binter, and P. Macheroux, “PLP-dependent enzymes as potential drug targets for protozoan diseases,” Biochimica et Biophysica Acta, vol. 1814, no. 11, pp. 1567–1576, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Storici, D. de Biase, F. Bossa et al., “Structures of γ-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5′-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with γ-ethynyl-GABA and with the antiepilepsy drug vigabatrin,” The Journal of Biological Chemistry, vol. 279, no. 1, pp. 363–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. G. F. Stamper, A. A. Morollo, and D. Ringe, “Reaction of alanine racemase with 1-aminoethylphosphonic acid forms a stable external aldimine,” Biochemistry, vol. 29, no. 20, pp. 10438–10445, 1998. View at Google Scholar
  62. F. Wu and H. Gehring, “Structural requirements for novel coenzyme-substrate derivatives to inhibit intracellular ornithine decarboxylase and cell proliferation,” FASEB Journal, vol. 23, no. 2, pp. 565–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. C. W. Tabor and H. Tabor, “Polyamines,” Annual Review of Biochemistry, vol. 53, pp. 749–790, 1983. View at Google Scholar · View at Scopus
  64. C. W. Tabor and H. Tabor, “Polyamines in microorganisms,” Microbiological Reviews, vol. 49, no. 1, pp. 81–99, 1985. View at Google Scholar · View at Scopus
  65. H. M. Wallace, A. V. Fraser, and A. Hughes, “A perspective of polyamine metabolism,” Biochemical Journal, vol. 376, no. 1, pp. 1–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Müller, A. Da'dara, K. Lüersen et al., “In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase,” The Journal of Biological Chemistry, vol. 275, no. 11, pp. 8097–8102, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. K. M. Ivanetich and D. V. Santi, “Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa,” FASEB Journal, vol. 4, no. 6, pp. 1591–1597, 1990. View at Google Scholar · View at Scopus
  68. D. J. Bzik, W. B. Li, T. Horii, and J. Inselburg, “Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 23, pp. 8360–8364, 1987. View at Google Scholar · View at Scopus
  69. T. Triglia and A. F. Cowman, “Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 15, pp. 7149–7153, 1994. View at Publisher · View at Google Scholar · View at Scopus
  70. J. L. Clarke, D. A. Scopes, O. Sodeinde, and P. J. Mason, “Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: a novel bifunctional enzyme in malaria parasites,” European Journal of Biochemistry, vol. 268, no. 7, pp. 2013–2019, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. D. J. Carucci, A. A. Witney, D. K. Muhia et al., “Guanylyl cyclase activity associated with putative bifunctional integral membrane proteins in Plasmodium falciparum,” The Journal of Biological Chemistry, vol. 275, no. 29, pp. 22147–22156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. I. B. Müller, R. Das Gupta, K. Lüersen, C. Wrenger, and R. D. Walter, “Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target,” Molecular and Biochemical Parasitology, vol. 160, no. 1, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. J. S. Heller, E. S. Canellakis, D. L. Bussolotti, and J. K. Coward, “Stable multisubstrate adducts as enzyme inhibitors. Potent inhibition of ornithine decarboxylase by N (5′-phosphopyridoxyl) ornithine,” Biochimica et Biophysica Acta, vol. 403, no. 1, pp. 197–207, 1975. View at Google Scholar · View at Scopus
  74. A. J. Bitonti, P. P. McCann, and A. Sjoerdsma, “Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony,” Experimental Parasitology, vol. 64, no. 2, pp. 237–243, 1987. View at Google Scholar · View at Scopus
  75. M. R. Hollingdale, P. P. McCann, and A. Sjoerdsma, “Plasmodium berghei: inhibitors of ornithine decarboxylase block exoerythrocytic schizogony,” Experimental Parasitology, vol. 60, no. 1, pp. 111–117, 1985. View at Google Scholar · View at Scopus
  76. A. J. Bitonti, J. A. Dumont, T. L. Bush et al., “Bis(benzyl)polyamine analogs inhibit the growth of chloroquine-resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with α-difluoromethylornithine cure murine malaria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 2, pp. 651–655, 1989. View at Google Scholar · View at Scopus
  77. C. J. Bacchi, H. C. Nathan, S. H. Hutner, P. P. McCann, and A. Sjoerdsma, “Polyamine metabolism: a potential therapeutic target in trypanosomes,” Science, vol. 210, no. 4467, pp. 332–334, 1980. View at Google Scholar · View at Scopus
  78. C. Burri and R. Brun, “Eflornithine for the treatment of human African trypanosomiasis,” Parasitology Research, vol. 90, supplement 1, pp. S49–S52, 2003. View at Google Scholar · View at Scopus
  79. A. Sjoerdsma and P. J. Schechter, “Eflornithine for African sleeping sickness,” The Lancet, vol. 354, no. 9174, p. 254, 1999. View at Google Scholar · View at Scopus
  80. H. W. Moon, A. Schwartz, M. J. Welch, P. P. McCann, and P. L. Runnels, “Experimental fecal transmission of human cryptosporidia to pigs, and attempted treatment with an ornithine decarboxylase inhibitor,” Veterinary Pathology, vol. 19, no. 6, pp. 700–707, 1982. View at Google Scholar · View at Scopus
  81. H. Mett, J. Stanek, J. A. Lopez-Ballester et al., “Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues,” Cancer Chemotherapy and Pharmacology, vol. 32, pp. 39–45, 1993. View at Google Scholar
  82. J. Stanek, J. Frei, H. Mett, P. Schneider, and U. Regenass, “2-Substituted 3-(aminooxy)propanamines as inhibitors of ornithine decarboxylase: synthesis and biological activity,” Journal of Medicinal Chemistry, vol. 35, no. 8, pp. 1339–1344, 1992. View at Google Scholar · View at Scopus
  83. R. Das Gupta, T. Krause-Ihle, B. Bergmann et al., “3-Aminooxy-1-aminopropane and derivatives have an antiproliferative effect on cultured Plasmodium falciparum by decreasing intracellular polyamine concentrations,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 7, pp. 2857–2864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Bulusu, V. Jayaraman, and H. Balaram, “Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum,” The Journal of Biological Chemistry, vol. 286, no. 11, pp. 9236–9245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. L. C. Berger, J. Wilson, P. Wood, and B. J. Berger, “Methionine regeneration and aspartate aminotransferase in prasitic protozoa,” Journal of Bacteriology, vol. 183, no. 15, pp. 4421–4434, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. P. K. Mehta, T. I. Hale, and P. Christen, “Aminotransferases: demonstration of homology and division into evolutionary subgroups,” European Journal of Biochemistry, vol. 214, no. 2, pp. 549–561, 1993. View at Google Scholar · View at Scopus
  87. R. Jain, R. Jordanova, I. B. Müller, C. Wrenger, and M. R. Groves, “Purification, crystallization and preliminary X-ray analysis of the aspartate aminotransferase of Plasmodium falciparum,” Acta Crystallographica F, vol. 66, no. 4, pp. 409–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Liu, E. Pozharski, B. W. Lepore et al., “Inactivation of Escherichia coli L-aspartate aminotransferase by (S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid reveals ‘A tale of two mechanisms’,” Biochemistry, vol. 46, no. 37, pp. 10517–10527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Wrenger, I. B. Müller, A. M. Silber, R. Jordanova, V. S. Lamzin, and M. R. Groves, “Aspartate aminotransferase—bridging carbohydrate and energy metabolism in Plasmodium falciparum,” Current Drug Metabolism, vol. 13, no. 3, pp. 332–336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Nzila, “The past, present and future of antifolates in the treatment of Plasmodium falciparum infection,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 6, pp. 1043–1054, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. V. Schirch and D. M. E. Szebenyi, “Serine hydroxymethyltransferase revisited,” Current Opinion in Chemical Biology, vol. 9, no. 5, pp. 482–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. N. Nirmalan, P. Wang, P. F. G. Sims, and J. E. Hyde, “Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum,” Molecular Microbiology, vol. 46, no. 1, pp. 179–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Agrawal, A. Kumar, V. Srivastava, and B. N. Mishra, “Cloning, expression, activity and folding studies of serine hydroxymethyltransferase: a target enzyme for cancer chemotherapy,” Journal of Molecular Microbiology and Biotechnology, vol. 6, no. 2, pp. 67–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. H. G. Eichler, R. Hubbard, and K. Snell, “The role of serine hydroxymethyltransferase in cell proliferation: DNA synthesis from serine following mitogenic stimulation of lymphocytes,” Bioscience Reports, vol. 1, no. 2, pp. 101–106, 1981. View at Google Scholar · View at Scopus
  95. A. Yoshioka, S. Tanaka, O. Hiraoka et al., “Deoxyribonucleoside triphosphate imbalance. 5-fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death,” The Journal of Biological Chemistry, vol. 262, no. 17, pp. 8235–8241, 1987. View at Google Scholar · View at Scopus
  96. S. Alfadhli and P. K. Rathod, “Gene organization of a Plasmodium falciparum serine hydroxymethyltransferase and its functional expression in Escherichia coli,” Molecular and Biochemical Parasitology, vol. 110, no. 2, pp. 283–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Sopitthummakhun, S. Maenpuen, Y. Yuthavong, U. Leartsakulpanich, and P. Chaiyen, “Serine hydroxymethyltransferase from Plasmodium vivax is different in substrate specificity from its homologues,” FEBS Journal, vol. 276, no. 15, pp. 4023–4036, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. T. C. França, P. G. Pascutti, T. C. Ramalho, and J. D. Figueroa-Villar, “A three-dimensional structure of Plasmodium falciparum serine hydroxymethyltransferase in complex with glycine and 5-formyl-tetrahydrofolate. Homology modeling and molecular dynamics,” Biophysical Chemistry, vol. 115, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Chu, C. H. Takimoto, D. Voeller, J. L. Grem, and C. J. Allegra, “Specific binding of human dihydrofolate reductase protein to Dihydrofolate reductase messenger RNA in vitro,” Biochemistry, vol. 32, no. 18, pp. 4756–4760, 1993. View at Publisher · View at Google Scholar · View at Scopus
  100. E. Salcedo, P. F. G. Sims, and J. E. Hyde, “A glycine-cleavage complex as part of the folate one-carbon metabolism of Plasmodium falciparum,” Trends in Parasitology, vol. 21, no. 9, pp. 406–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. G. E. Garcia, R. A. Wirtz, J. R. Barr, A. Woolfitt, and R. Rosenbergt, “Xanthurenic acid induces gametogenesis in Plasmodium, the malaria parasite,” The Journal of Biological Chemistry, vol. 273, no. 20, pp. 12003–12005, 1998. View at Publisher · View at Google Scholar · View at Scopus